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Abstract
Background: To report the negative effect of Nd: Yag (Neodymium-doped: Yttrium Aluminium Garnet) laser
capsulotomy on the intraocular pressure (IOP) and the trabeculectomy bleb integrity, in a small series of eyes, both
trabeculectomised and pseudophakic, following the laser application for the management of posterior capsular
opacification (PCO).
Methods: This is a retrospective, non-comparative interventional case series study, in which 20 trabeculectomised
and pseudophakic eyes from 15 patients, with otherwise well functioning blebs, were presented with uncontrolled
IOP, in a variable distance of time following the application of YAG laser capsulotomy. Student paired t-test
confirmed a statistically significant difference (P < 0.05) between IOP before Nd: YAG laser capsulotomy (16 mmHg
± 3 mmHg) and the respective one, 2 to 6 months after Nd: Yag capsulotomy (34.5 ± 11 mmHg).
Results: All of the cases failed to respond to conservative treatment and were successfully managed with the
implantation of Ahmed drainage devices. All patients showed flat filtering bleb and uncontrolled IOP (34.5 ±
11 mmHg), under maximum topical treatment, in a period of 2 to 6 months following Nd: YAG laser caspulotomy.
The implantation of Ahmed valve proved to be effective treatment for these patients (IOP < 21 mmHg).
Conclusions: Although Nd: Yag laser capsulotomy is considered a safe surgical procedure and usually is done
without second thought, in this series of eyes, it is postulated that it may be responsible for the deregulation of the
filtering bleb and subsequent loss of IOP control. We consider that laser capsulotomy should be performed with
caution, especially in eyes with previous trabeculectomy. Also close monitoring of the intraocular pressure and
assessment of eventual bleb morphology variations in the follow-up period is mandatory. Further studies are
needed in order to confirm our findings.
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Background
Posterior capsule opacification (PCO) represents one
of the commonest delayed post-operative complica-
tions following extracapsular cataract extraction and
phacoemulsification. According to literature reports,
the incidence of PCO after cataract surgery and intra-
ocular lens implantation varies between 15 and 43%
[1–3].
Although Nd: YAG laser (Neodymium-doped: Yttrium
Aluminium Garnet laser) posterior capsulotomy is a
common procedure for the management of PCO, it has
been associated with several complications, some of
which severe.
Short term elevation in the intraocular pressure (IOP
spikes) following Nd: YAG laser capsulotomy has been
well documented [4, 5] and several studies have shown
the long term effect of this procedure on IOP, in non
glaucomatous patients [6–8].
However, only few published studies evaluate the long
term changes in IOP, after Nd: YAG laser capsulotomy,
in eyes with glaucoma that have previously undergone
trabeculectomy [9, 10].
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The purpose of the present study is to report the effect
of Nd: Yag laser capsulotomy on IOP control and trabe-
culectomy bleb integrity in a series of otherwise well-
controlled glaucomatous patients, and to document the
inadequate control of the IOP with medical treatment
and the success of further surgical management.
Methods
The present study represents a retrospective, non-
comparative, interventional, case series. The study ad-
heres to the tenets of the Declaration of Helsinki and
was performed after the permission of the institutional
ethics committee of “G.Gennimatas” General Hospital.
Patients were informed about the study procedure and
eventual ocular image publication and provided written,
informed consent.
We reviewed the medical records of 15 patients (20
eyes) who were referred to our glaucoma department for
management of uncontrolled IOP, 2 to 6 months after
Nd; YAG laser capsulotomy (Table 1).
All eyes had primarily undergone standard trabeculect-
omy and cataract extraction followed (period between
trabeculectomy and phacoemulsification ranged between
1 and 7 years).
Trabeculectomy was performed by the same surgeon
(D.P.). Following peribulbar anaesthesia with lidocaine 1%,
the eye was prepared and draped. A 7-0 silk suture was
placed half thickness in the superior cornea as a traction
suture. All operations were performed with fornix-based
conjunctival flaps centered at 12 o’ clock and a rectangular
scleral flap of approximately 3 × 5 mm.
A knife operated sclerectomy (1 × 2 mm) was followed
by a basic-peripheral iridectomy. After the verification of
the ostium patency, the scleral flap was closed with 2
10-0 nylon sutures, one in each angle. At last, tenon’s
and conjunctiva were advanced and sutured at the level
of the limbus usually with 2 to 3 10-0 nylon sutures.
Postoperatively, a topical fixed combination of chlor-
amphenicol and dexamethasone six times daily for
4 weeks followed by gradual tapering was used.
One to 7 years after the trabeculectomy the eyes
underwent cataract extraction, phacoemulsification (n =
16) or extracapsular cataract extraction (n = 4).
All cases were uncomplicated, with in-the-bag intraoc-
ular lens implantation. Subsequently, they developed
posterior capsular opacification and underwent Nd;
YAG laser capsulotomy.
Before the laser procedure their IOPs were within our
estimated target pressure, with either the use of topical
medication (three eyes) or without any (the rest).
Nd; YAG laser capsulotomy was performed in all the
eyes by the same laser device, but by various operators
and usually with variable laser settings. Nontheless, the
amount of total energy never exceeded the 10 mJ. A cap-
sulotomy contact lens was not used in any of the cases.
Apraclonidine was administered in all the eyes immedi-
ately on completion of the Nd: YAG laser posterior cap-
sulotomy to minimize a postoperative intraocular
pressure spike and patient’s IOP was measured one hour
after the laser procedure.
A short course of topical steroids was used following
the procedure and follow-up appointment was scheduled
for a week after.
Data about the pre and post-operative best-corrected
visual acuity and clinical examination (including gonio-
scopy and fundus examination), pre and post-operative
IOP (Goldmann applanation tonometry) and bleb integ-
rity as well as the pre and post-operative medication
were collected and analysed.
Results
Twenty eyes of fifteen patients were included in the ana-
lysis. The mean age of the patients was 56.2 ± 24.9 (range
14–77 years) and there was no gender preponderance
(eight males, seven females). Seven patients (11 eyes) suf-
fered from chronic open angle glaucoma, four patients
(five eyes) had pseudoexfoliative glaucoma, two patients
(two eyes) had chronic angle closure glaucoma and two
patients (two eyes) had uveitic glaucoma (Table 1).
The mean IOP before Nd: YAG laser capsulotomy was
16 mmHg (±3 mmHg) without any glaucoma treatment
in 17 eyes. Three eyes required the administration of a
single medication for IOP control.
Nd; YAG laser capsulotomy was performed between
12 and 42 months after the cataract extraction and the
intraocular lens (IOL) implantation. Mean IOP 2 to 6
months after Nd; YAG laser capsulotomy was 34.5 ±
11 mmHg (student paired t-test, P < 0.05 compared to
the pre-yag laser IOP), with all patients under maximum
Table 1 Patients’ characteristics
Patients/Eyes 15/20
Age (yrs)










SD standard deviation, IOP intraocular pressure, POAG primary-open angle
glaucoma, PXG pseudoexfoliative glaucoma, UG uveitic glaucoma, CACG
chronic angle closure glaucoma, BCVA best corrected visual acuity
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topical treatment. Furthermore, in four patients oral ac-
etazolamide (250 mg or 125 mg three times a day) was
administered in order to achieve adequate IOP control.
All patients underwent Ahmed valve implantation with
a mean follow-up of 8.5 months during which IOP was
adequately controlled (<21 mmHg) and either topical or
systemic antiglaucomatous medication was required.
Discussion
In the present study, a series of patients with well func-
tioning bleb and controlled IOP after trabeculectomy
and secondary cataract extraction demonstrated loss of
the bleb integrity and IOP control, following Nd: YAG
laser capsulotomy for PCO. Thus, further surgical treat-
ment (Ahmed valve implantation) was required in order
to control the IOP.
The effect of Nd: YAG laser capsulotomy on the IOP
either during the short post-laser period or in the long
term is well documented in the literature, both in the
general population, as well as in glaucomatous patients.
Several studies have shown that there is high incidence
of IOP rise in the immediate postoperative period fol-
lowing Nd: YAG laser capsulotomy [4, 6, 11]. The IOP
elevation initiates within hours following the procedure
and the maximum IOP values are recorded within the
first 2 days [11–13]. The incidence of newly diagnosed
glaucoma due to sustained IOP elevation after Nd: YAG
laser capsulotomy has been reported to be up to 6% [11,
13, 14]. Furthermore, pre-existing glaucoma is a well
known risk factor for transient IOP elevations after Nd:
YAG laser capsulotomy [10, 11, 13]. Several studies have
documented the protective effect of hypotensive pre-
treatment in glaucomatous patients undergoing laser
capsulotomy [15].
The underlying mechanism of this rise in IOP follow-
ing Nd: YAG laser capsulotomy remains unclear. Patho-
physiological hypotheses include effects on the ciliary
body function caused by laser shock waves, a neurohu-
moral increase in the IOP, structural effects of laser en-
ergy on sodium hyaluronate and finally, mechanical
blockage of the trabecular meshwork by various debris,
such as fragments from the disrupted posterior capsule
or vitreous [4, 10].
However, there are very few studies in the literature
evaluating the effect of Nd: YAG laser capsulotomy on
the IOP of pseudophakic patients that have previously
undergone well functioning filtering procedures. Zeyen
et al. examined 20 patients that had undergone com-
bined cataract–glaucoma procedure followed by Nd:
YAG capsulotomy, with 3 months interval and con-
cluded that the capsulotomy does not significantly alter
the bleb function or the number of glaucoma medica-
tions used after the procedure [9]. Recently, Lin et al.
published their results from the follow up of 69
glaucoma patients that underwent Nd: YAG laser capsu-
lotomy. Among them, 42 patients had previously under-
gone combined cataract and glaucoma procedure. The
authors concluded that the loss of baseline IOP control
after Nd: YAG laser capsulotomy is common in glau-
coma patients, however it is unclear whether this in-
crease in the IOP is related directly to the laser
procedure or whether this is an independent progression
of the patient’s glaucoma [10].
In all our cases, patients demonstrated loss of IOP
control, in spite of maximum topical treatment, a few
months after Nd: YAG laser capsulotomy. On slit lamp
examination the appearance of the bleb was mostly flat.
All eyes had previously undergone trabeculectomy with
well formed and functioning blebs and IOP was ad-
equately controlled in all follow-up visits prior to the
laser procedure. It is highly unlikely that this loss of IOP
control, documented after Nd: YAG capsulotomy, is a
natural progression of glaucoma disease and not directly
related to the procedure.
It is postulated that the underlying mechanism of this
complication could be the ab interno mechanical blockage
of the filtering bleb. Thus, debris from the disrupted pos-
terior capsule or liquefied vitreous, following capsulotomy,
is considered to pass through the site of the iridectomy,
obstructing the sclerostomy In addition, the fact that in all
the affected eyes the size of the anterior capsulotomy was
quite large should be taken into consideration, as this
event probably facilitated the transportation of debris or
vitreous from the posterior to the anterior chamber (AC),
which subsequently blocked the filtering bleb [16].
The above taken into consideration, our team pro-
ceeded to the implantation of an Ahmed valve in all
eyes. The decision for the use of a drainage device was
based on the fact that the inner aperture of the tube
could be placed deep inside the anterior chamber, trans-
ferring the acting position of the sclerostomy away from
the corneo-scleral angle, thus reducing the chance of oc-
clusion by vitreous or debris.
Our study has some obvious limitations. It is retro-
spective with a limited number of patients without a
control group. Nonetheless, to the best of our knowledge
it represents one of the very few reports addressing the
influence of Nd: YAG laser capsulotomy on IOP in tra-
beculectomised eyes and suggesting the mechanical
blockage of the sclerostomy as a possible pathophysio-
logical mechanism. More extensive longitudinal and pro-
spective studies are needed to verify our hypothesis.
This will facilitate patient counselling.
Conclusion
In conclusion, it is postulated that Nd: Yag capsulotomy
may be responsible for the deregulation of the trabecu-
lectomy bleb and subsequent loss of IOP control in
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previously trabeculectomized eyes undergoing manage-
ment of PCO. Further comparative studies are needed in
order to confirm our findings.
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